Results 271 to 280 of about 15,139,370 (299)
Some of the next articles are maybe not open access.
Microbiota and immune-related adverse events in cancer immunotherapy
Nature Reviews CancerIn response to treatment with immune checkpoint inhibitors (ICIs), patients with cancer can develop immune-related adverse events (irAEs), which are off-target toxicities affecting non-tumour tissues. Development of an irAE can require cessation of ICI treatment and cause additional morbidities, unrelated to cancer.
Sarah M. Schneider +4 more
openaire +2 more sources
Hypophysitis: Nursing Management of Immune-Related Adverse Events
Clinical Journal of Oncology Nursing, 2017Immunotherapy can treat cancer and prevent future cancer relapse by enhancing the body's immune system. With novel immunotherapeutic agents like checkpoint inhibitors come unique immune-related adverse events. Hypophysitis, one of the lesser known immune-related complications, may be observed in patients receiving checkpoint inhibitors.
openaire +2 more sources
The Current and Future of Biomarkers of Immune Related Adverse Events
Immunology and Allergy Clinics of North AmericaWith their groundbreaking clinical responses, immune checkpoint inhibitors (ICIs) have ushered in a new chapter in cancer therapeutics. However, they are often associated with life-threatening or organ-threatening autoimmune/autoinflammatory phenomena, collectively termed immune-related adverse events (irAEs). In this review, we will first describe the
William, Bracamonte-Baran, Sang T, Kim
openaire +3 more sources
Patient Voices in Rheumatic Immune-related Adverse Events
Rheumatic Disease Clinics of North AmericaPatients with cancer considering immune checkpoint inhibitor (ICI) therapy often look for health information and peer support through online communities. The authors used social media content analysis to obtain the perspectives of patients receiving ICI treatment about immune-related adverse events (irAEs), with particular focus on rheumatological ...
Kara N, Corps +2 more
openaire +2 more sources
[Management of immune-related adverse events].
Urologie (Heidelberg, Germany)With the implementation of immunotherapy, a completely new, broad spectrum of side effects has emerged in oncology-the immune-related adverse events (irAEs). Their management differs greatly from that of classic cytotoxic side effects and is based primarily on corticosteroids, immunomodulatory agents, and treatment interruptions.
Marika Henriette, Princk +2 more
openaire +1 more source
A Review of Cancer Immunotherapy Toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Immune-related cutaneous adverse events
Annals of Allergy, Asthma & Immunology, 2021openaire +1 more source
Moving Towards Personalized Treatments of Immune-Related Adverse Events
Nature Reviews Clinical Oncology, 2020Marie Hudson +2 more
exaly
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events
Journal of Thoracic Oncology, 2021Bianca D Santomasso +2 more
exaly

